Table 4.
OR | 95% CI | |
Age in years | 0.97 | 0.96, 0.97 |
Female | 0.75 | 0.67, 0.85 |
Underlying conditions and comorbidities | ||
Cerebrovascular disease | 0.61 | 0.50, 0.73 |
Chronic obstructive pulmonary disease | 0.62 | 0.54, 0.72 |
Congestive heart failure | 1.09 | 0.89, 1.34 |
Coronary heart disease | 0.98 | 0.84, 1.14 |
Dementia | 0.44 | 0.27, 0.70 |
Diabetes mellitus | 1.47 | 1.27, 1.70 |
Hypertension | 0.53 | 0.47, 0.59 |
Kidney disease | 1.24 | 0.84, 1.83 |
Liver cirrhosis† | 0.31 | 0.07, 1.38 |
Metastatic carcinoma | 1.11 | 0.87, 1.41 |
Nephritis, nephrotic syndrome, and nephrosis | 0.49 | 0.35, 0.69 |
Peripheral vascular disease | 1.40 | 1.08, 1.82 |
Rheumatic disease | 1.27 | 0.91, 1.77 |
Syndrome of inappropriate antidiuretic hormone | 0.06 | 0.04, 0.08 |
Medications known to cause hyponatremia | 1.08 | 0.95, 1.22 |
* Hyponatremia was defined as serum sodium < 136 mmol/L. A negative test was defined as the presence of an outpatient professional claim with no ICD-9-CM code for hyponatremia or the absence of any outpatient professional claims within 15 days before or after the laboratory claim indicating hyponatremia.
† Indicates that the condition was present in < 1% of the population.
Abbreviations: OR indicates odds ratio; and CI, confidence interval.